​
​

TFF Pharmaceuticals Ownership 2024 | Who Owns TFF Pharmaceuticals Now?

OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

31.87%

Insider Ownership

3.31%

Retail Ownership

64.82%

Institutional Holders

38.00

TFF Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----61-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----2,509-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----2,747-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----49,238-100.00%-Dec 31, 2023
STATE STREET CORP----69,929-100.00%-Dec 31, 2023
VANGUARD GROUP INC----846,884-100.00%-Dec 31, 2023
MORGAN STANLEY----1,816-100.00%-Dec 31, 2023
HM PAYSON & CO----1,500-100.00%-Dec 31, 2023
GROUP ONE TRADING, L.P.----1,381-100.00%-Dec 31, 2023
THOMPSON DAVIS & CO., INC.----10,000-100.00%-Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC----155,500-100.00%-Dec 31, 2023
CARLSON CAPITAL L P----4,875,000-100.00%-Dec 31, 2023
NATIONS FINANCIAL GROUP INC, /IA/ /ADV----12,500-100.00%-Dec 31, 2023
GAGNON SECURITIES LLC----162,565-100.00%-Dec 31, 2023
PRINCETON CAPITAL MANAGEMENT LLC----18,161-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----253,640-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----71,518-100.00%-Dec 31, 2023
JANNEY MONTGOMERY SCOTT LLC----14,350-100.00%-Dec 31, 2023
BLACKROCK INC.----213,085-100.00%-Dec 31, 2023
SIGMA PLANNING CORP----145,050-100.00%-Dec 31, 2023

TFF Pharmaceuticals's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----61-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----2,509-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----2,747-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----49,238-100.00%-Dec 31, 2023
STATE STREET CORP----69,929-100.00%-Dec 31, 2023
VANGUARD GROUP INC----846,884-100.00%-Dec 31, 2023
MORGAN STANLEY----1,816-100.00%-Dec 31, 2023
HM PAYSON & CO----1,500-100.00%-Dec 31, 2023
GROUP ONE TRADING, L.P.----1,381-100.00%-Dec 31, 2023
THOMPSON DAVIS & CO., INC.----10,000-100.00%-Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC----155,500-100.00%-Dec 31, 2023
CARLSON CAPITAL L P----4,875,000-100.00%-Dec 31, 2023
NATIONS FINANCIAL GROUP INC, /IA/ /ADV----12,500-100.00%-Dec 31, 2023
GAGNON SECURITIES LLC----162,565-100.00%-Dec 31, 2023
PRINCETON CAPITAL MANAGEMENT LLC----18,161-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----253,640-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----71,518-100.00%-Dec 31, 2023
JANNEY MONTGOMERY SCOTT LLC----14,350-100.00%-Dec 31, 2023
BLACKROCK INC.----213,085-100.00%-Dec 31, 2023
SIGMA PLANNING CORP----145,050-100.00%-Dec 31, 2023

The largest TFF Pharmaceuticals shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of TFF Pharmaceuticals (TFFP), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----61-100.00%-Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.----1,000-100.00%-Dec 31, 2023
GROUP ONE TRADING, L.P.----1,381-100.00%-Dec 31, 2023
HM PAYSON & CO----1,500-100.00%-Dec 31, 2023
MORGAN STANLEY----1,816-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----2,509-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----2,747-100.00%-Dec 31, 2023
VENTURI WEALTH MANAGEMENT, LLC----8,273-100.00%-Dec 31, 2023
THOMPSON DAVIS & CO., INC.----10,000-100.00%-Dec 31, 2023
QUANTUM PRIVATE WEALTH, LLC----11,082-100.00%-Dec 31, 2023
MERIDIAN WEALTH ADVISORS, LLC----11,577-100.00%-Dec 31, 2023
NATIONS FINANCIAL GROUP INC, /IA/ /ADV----12,500-100.00%-Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----13,879-100.00%-Dec 31, 2023
JANNEY MONTGOMERY SCOTT LLC----14,350-100.00%-Dec 31, 2023
PRINCETON CAPITAL MANAGEMENT LLC----18,161-100.00%-Dec 31, 2023
ORG PARTNERS LLC----18,500-100.00%-Dec 31, 2023
CI PRIVATE WEALTH, LLC----19,000-100.00%-Dec 31, 2023
XTX TOPCO LTD----21,885-100.00%-Dec 31, 2023
FERMATA ADVISORS, LLC----24,032-100.00%-Dec 31, 2023
WESTSIDE INVESTMENT MANAGEMENT, INC.----43,600-100.00%-Dec 31, 2023

As of Dec 31 2023, TFF Pharmaceuticals's largest institutional buyer is JPMORGAN CHASE & CO. The company purchased -61.00 stocks of TFFP, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CARLSON CAPITAL L P----4,875,000-100.00%-Dec 31, 2023
AIGH CAPITAL MANAGEMENT LLC----2,655,235-100.00%-Dec 31, 2023
DRW SECURITIES, LLC----1,000,000-100.00%-Dec 31, 2023
VANGUARD GROUP INC----846,884-100.00%-Dec 31, 2023
WORTH VENTURE PARTNERS, LLC----646,832-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----253,640-100.00%-Dec 31, 2023
BLACKROCK INC.----213,085-100.00%-Dec 31, 2023
GAGNON SECURITIES LLC----162,565-100.00%-Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC----155,500-100.00%-Dec 31, 2023
SIGMA PLANNING CORP----145,050-100.00%-Dec 31, 2023
UBS GROUP AG----91,720-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----71,518-100.00%-Dec 31, 2023
STATE STREET CORP----69,929-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----49,238-100.00%-Dec 31, 2023
WESTSIDE INVESTMENT MANAGEMENT, INC.----43,600-100.00%-Dec 31, 2023
FERMATA ADVISORS, LLC----24,032-100.00%-Dec 31, 2023
XTX TOPCO LTD----21,885-100.00%-Dec 31, 2023
CI PRIVATE WEALTH, LLC----19,000-100.00%-Dec 31, 2023
ORG PARTNERS LLC----18,500-100.00%-Dec 31, 2023
PRINCETON CAPITAL MANAGEMENT LLC----18,161-100.00%-Dec 31, 2023

As of Dec 31 2023, TFF Pharmaceuticals's biggest institutional seller is CARLSON CAPITAL L P. The company sold -4.88M shares of TFFP, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CARLSON CAPITAL L P----4,875,000-100.00%-Dec 31, 2023
AIGH CAPITAL MANAGEMENT LLC----2,655,235-100.00%-Dec 31, 2023
DRW SECURITIES, LLC----1,000,000-100.00%-Dec 31, 2023
VANGUARD GROUP INC----846,884-100.00%-Dec 31, 2023
WORTH VENTURE PARTNERS, LLC----646,832-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----253,640-100.00%-Dec 31, 2023
BLACKROCK INC.----213,085-100.00%-Dec 31, 2023
GAGNON SECURITIES LLC----162,565-100.00%-Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC----155,500-100.00%-Dec 31, 2023
SIGMA PLANNING CORP----145,050-100.00%-Dec 31, 2023
UBS GROUP AG----91,720-100.00%-Dec 31, 2023
MILLENNIUM MANAGEMENT LLC----71,518-100.00%-Dec 31, 2023
STATE STREET CORP----69,929-100.00%-Dec 31, 2023
NORTHERN TRUST CORP----49,238-100.00%-Dec 31, 2023
WESTSIDE INVESTMENT MANAGEMENT, INC.----43,600-100.00%-Dec 31, 2023
FERMATA ADVISORS, LLC----24,032-100.00%-Dec 31, 2023
XTX TOPCO LTD----21,885-100.00%-Dec 31, 2023
CI PRIVATE WEALTH, LLC----19,000-100.00%-Dec 31, 2023
ORG PARTNERS LLC----18,500-100.00%-Dec 31, 2023
PRINCETON CAPITAL MANAGEMENT LLC----18,161-100.00%-Dec 31, 2023
JANNEY MONTGOMERY SCOTT LLC----14,350-100.00%-Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----13,879-100.00%-Dec 31, 2023
NATIONS FINANCIAL GROUP INC, /IA/ /ADV----12,500-100.00%-Dec 31, 2023
MERIDIAN WEALTH ADVISORS, LLC----11,577-100.00%-Dec 31, 2023
QUANTUM PRIVATE WEALTH, LLC----11,082-100.00%-Dec 31, 2023
THOMPSON DAVIS & CO., INC.----10,000-100.00%-Dec 31, 2023
VENTURI WEALTH MANAGEMENT, LLC----8,273-100.00%-Dec 31, 2023
WELLS FARGO & COMPANY/MN----2,747-100.00%-Dec 31, 2023
BANK OF AMERICA CORP /DE/----2,509-100.00%-Dec 31, 2023
MORGAN STANLEY----1,816-100.00%-Dec 31, 2023
HM PAYSON & CO----1,500-100.00%-Dec 31, 2023
GROUP ONE TRADING, L.P.----1,381-100.00%-Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.----1,000-100.00%-Dec 31, 2023
JPMORGAN CHASE & CO----61-100.00%-Dec 31, 2023

TFF Pharmaceuticals's largest sold out institutional shareholder by shares sold is CARLSON CAPITAL L P, sold -4.88M shares, valued at -, as of undefined.

TFF Pharmaceuticals Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
IndexIQ ETF Trust0.01%31,121--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.01%5,786--Mar 31, 2024
BRIDGEWAY FUNDS INC0.01%21,300--Mar 28, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.00%37,350--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%831,459--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%236,571--Feb 29, 2024
Principal Exchange-Traded Funds0.00%4,598--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%11,966--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%6,067--Mar 31, 2024
FLEXSHARES TRUST0.00%10,422--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%34,369-9,638-21.90%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%16,58516,585-Feb 29, 2024
Series Portfolios Trust0.00%260--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%3,527--Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%242--Mar 31, 2024
EQ ADVISORS TRUST0.00%6,084--Mar 31, 2024
ADVANCED SERIES TRUST0.00%16,700--Mar 28, 2024
AMERICAN CENTURY ETF TRUST0.00%349--Feb 29, 2024
iSHARES TRUST0.00%18,016--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%715--Mar 31, 2024

TFF Pharmaceuticals's largest mutual fund holder by % of total assets is "IndexIQ ETF Trust", owning 31.12K shares, compromising 0.01% of its total assets.

TFF Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 233818.75%
30 Jun, 2332-13.51%
31 Mar, 2337-13.95%
31 Dec, 2243-10.42%
30 Sep, 2248-2.04%
30 Jun, 22492.08%
31 Mar, 2248-15.79%
31 Dec, 2157-6.56%
30 Sep, 2161-4.69%
30 Jun, 2164-7.25%
31 Mar, 216930.19%
31 Dec, 205315.22%
30 Sep, 2046228.57%
30 Jun, 2014-
31 Mar, 2014-12.50%
31 Dec, 1916-

As of 30 Sep 23, 38 institutions are holding TFF Pharmaceuticals's shares, representing an increase of 18.75% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 2311,534,63680.06%
30 Jun, 236,406,076-8.36%
31 Mar, 236,990,738-3.13%
31 Dec, 227,216,92570.57%
30 Sep, 224,231,1041.03%
30 Jun, 224,187,815-2.57%
31 Mar, 224,298,446-7.33%
31 Dec, 214,638,207-20.61%
30 Sep, 215,842,0323.00%
30 Jun, 215,671,741-19.90%
31 Mar, 217,080,8659.35%
31 Dec, 206,475,14220.04%
30 Sep, 205,394,151221.94%
30 Jun, 201,675,53357.97%
31 Mar, 201,060,69211.53%
31 Dec, 19951,037-

TFF Pharmaceuticals (TFFP) has 11.53M shares outstanding as of 30 Sep 23, up 80.06% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 2331.87%10.17%
30 Jun, 2317.70%4.74%
31 Mar, 2319.32%3.33%
31 Dec, 2224.07%8.71%
30 Sep, 2216.62%6.10%
30 Jun, 2216.50%5.75%
31 Mar, 2216.94%4.85%
31 Dec, 2118.69%3.52%
30 Sep, 2123.03%4.61%
30 Jun, 2122.36%2.39%
31 Mar, 2130.60%3.04%
31 Dec, 2031.70%4.74%
30 Sep, 2025.85%33.49%
30 Jun, 208.79%28.21%
31 Mar, 205.58%12.68%
31 Dec, 196.63%-

As of 30 Sep 23, TFF Pharmaceuticals is held by 31.87% institutional shareholders, representing a 10.17% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 2316220.00%
30 Jun, 235-66.67%
31 Mar, 2315-21.05%
31 Dec, 2219-5.00%
30 Sep, 2220-4.76%
30 Jun, 222131.25%
31 Mar, 2216-40.74%
31 Dec, 2127-3.57%
30 Sep, 2128-9.68%
30 Jun, 2131-24.39%
31 Mar, 214136.67%
31 Dec, 2030-9.09%
30 Sep, 2033371.43%
30 Jun, 207-12.50%
31 Mar, 208-50.00%
31 Dec, 1916-

16 institutional shareholders have increased their position in TFFP stock as of 30 Sep 23 compared to 5 in the previous quarter (a 220.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 238-42.86%
30 Jun, 2314133.33%
31 Mar, 236-40.00%
31 Dec, 2210-9.09%
30 Sep, 221137.50%
30 Jun, 228-38.46%
31 Mar, 2213-7.14%
31 Dec, 2114-17.65%
30 Sep, 2117-5.56%
30 Jun, 211850.00%
31 Mar, 2112-
31 Dec, 201271.43%
30 Sep, 20775.00%
30 Jun, 204-
31 Mar, 204-
31 Dec, 19--

8 institutional shareholders have reduced their position in TFFP stock as of 30 Sep 23 compared to 14 in the previous quarter (a -42.86% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 233818.75%11,534,63680.06%31.87%10.17%16220.00%8-42.86%
30 Jun, 2332-13.51%6,406,076-8.36%17.70%4.74%5-66.67%14133.33%
31 Mar, 2337-13.95%6,990,738-3.13%19.32%3.33%15-21.05%6-40.00%
31 Dec, 2243-10.42%7,216,92570.57%24.07%8.71%19-5.00%10-9.09%
30 Sep, 2248-2.04%4,231,1041.03%16.62%6.10%20-4.76%1137.50%
30 Jun, 22492.08%4,187,815-2.57%16.50%5.75%2131.25%8-38.46%
31 Mar, 2248-15.79%4,298,446-7.33%16.94%4.85%16-40.74%13-7.14%
31 Dec, 2157-6.56%4,638,207-20.61%18.69%3.52%27-3.57%14-17.65%
30 Sep, 2161-4.69%5,842,0323.00%23.03%4.61%28-9.68%17-5.56%
30 Jun, 2164-7.25%5,671,741-19.90%22.36%2.39%31-24.39%1850.00%
31 Mar, 216930.19%7,080,8659.35%30.60%3.04%4136.67%12-
31 Dec, 205315.22%6,475,14220.04%31.70%4.74%30-9.09%1271.43%
30 Sep, 2046228.57%5,394,151221.94%25.85%33.49%33371.43%775.00%
30 Jun, 2014-1,675,53357.97%8.79%28.21%7-12.50%4-
31 Mar, 2014-12.50%1,060,69211.53%5.58%12.68%8-50.00%4-
31 Dec, 1916-951,037-6.63%-16---

TFF Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 08, 2024Weisman Harlan Fdirector, officer President and CEOA-AwardBuy27,480--842,095
Jul 08, 2024Weisman Harlan Fdirector, officer President and CEOA-AwardBuy27,480$1.82$50.01K27,480
Jul 08, 2024Lee Catherine Chai-zondirector-A-AwardBuy1,583--1,583
Jul 08, 2024Lee Catherine Chai-zondirector-A-AwardBuy1,583$1.82$2.88K1,583
Jul 08, 2024MILLS ROBERT Sdirector-A-AwardBuy3,165--59,145
Jul 08, 2024MILLS ROBERT Sdirector-A-AwardBuy3,165$1.82$5.76K3,165
Jul 08, 2024Roberts Brandidirector-A-AwardBuy3,165--23,165
Jul 08, 2024Roberts Brandidirector-A-AwardBuy3,165$1.82$5.76K3,165
Jul 08, 2024COLEMAN KIRK ALLENofficer Chief Financial OfficerA-AwardBuy10,184--45,859
Jul 08, 2024COLEMAN KIRK ALLENofficer Chief Financial OfficerA-AwardBuy10,184$1.82$18.53K10,184
Jul 08, 2024Mikhak Zamanehofficer Chief Medical OfficerA-AwardBuy10,184--145,184
Jul 08, 2024Mikhak Zamanehofficer Chief Medical OfficerA-AwardBuy10,184$1.82$18.53K10,184
Jul 08, 2024ROCAMBOLI STEPHENdirector-A-AwardBuy3,165--39,165
Jul 08, 2024ROCAMBOLI STEPHENdirector-A-AwardBuy3,165$1.82$5.76K3,165
Jul 08, 2024KING THOMAS BRAXTONdirector-A-AwardBuy1,583--1,583
Jul 08, 2024KING THOMAS BRAXTONdirector-A-AwardBuy1,583$1.82$2.88K1,583
Apr 22, 2024KING THOMAS BRAXTONdirector-A-AwardBuy3,110--3,110
Apr 22, 2024Patane Michael Adirector-A-AwardBuy3,556--3,556
Apr 22, 2024Lee Catherine Chai-zondirector-A-AwardBuy3,556--3,556
Apr 22, 2024MILLS ROBERT Sdirector-A-AwardBuy4,667--4,667

TFF Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 20236--
Q3 202362300.00%
Q1 202351500.00%
Q4 20228--
Q3 2022-2-
Q2 20227--
Q1 2022-1-
Q3 20213--
Q2 20212--
Q1 2021112250.00%
Q4 2020102441.67%
Q3 202096150.00%
Q2 20205--
Q1 20201--
Q4 20192912241.67%

6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by TFF Pharmaceuticals's insiders, as of Q4 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2023---
Q3 202362300.00%
Q1 20234--
Q4 20223--
Q3 2022-1-
Q2 20227--
Q1 2022---
Q3 20212--
Q2 20212--
Q1 2021-11-
Q4 20201156.67%
Q3 2020-1-
Q2 20205--
Q1 2020---
Q4 20198--

As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of TFF Pharmaceuticals's stocks.

TFF Pharmaceuticals Peer Ownership

TickerCompany
CUECue Biopharma, Inc.
ONCROncorus, Inc.
ORGSOrgenesis Inc.
TCRXTScan Therapeutics, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
GANXGain Therapeutics, Inc.
DRMADermata Therapeutics, Inc.
ANTXAN2 Therapeutics, Inc.
LTRNLantern Pharma Inc.
INABIN8bio, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
CGTXCognition Therapeutics, Inc.
ANVSAnnovis Bio, Inc.
ANIXAnixa Biosciences, Inc.
LIFEaTyr Pharma, Inc.
INMBINmune Bio, Inc.
IMNMImmunome, Inc.

TFFP Ownership FAQ

TFF Pharmaceuticals is owned by institutional shareholders (31.87%), insiders (3.31%), and public (64.82%). The largest institutional shareholder of TFF Pharmaceuticals is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is IndexIQ ETF Trust (0.01% of total shares).

TFF Pharmaceuticals's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.

As of Sep 2023, there are 38 institutional shareholders of TFF Pharmaceuticals.

JPMORGAN CHASE & CO owns 0 shares of TFF Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

As of Dec 2023, BANK OF AMERICA CORP /DE/ holds 0 shares of TFF Pharmaceuticals (TFFP), compromising 0% of the company, valued at $0.

WELLS FARGO & COMPANY/MN is the third largest holder of TFF Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).